Predictors of chronic lung disease in the 'CPAP era'

Journal of Paediatrics and Child Health

Volumn 40, Issue 5-6, 2004, Pages 290-294

  Groves, A M ^a   Briggs, K A ^a   Kuschel, C A ^a   Harding, J E ^a  

^a NATIONAL WOMEN S HOSPITAL   (New Zealand)

Author keywords

Chronic lung disease; Nasal CPAP; Preterm

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; CAUSE OF DEATH; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEWBORN; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PREDICTION; PRIORITY JOURNAL; RELIABILITY; RETROSPECTIVE STUDY; RISK FACTOR;

CHRONIC DISEASE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; LUNG DISEASES; NEW ZEALAND; POSITIVE-PRESSURE RESPIRATION; PULMONARY VENTILATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 3042558094     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2004.00365.x     Document Type: Article

References (29)

1. Darlow BA, Cust AE, Donoghue DA. Improved outcomes for very low birthweight infants: evidence from New Zealand national population based data. Arch. Dis. Child Fetal Neonatal Ed. 2003; 88: F23-8.
2. Avery ME, Tooley WH, Keller JB et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987; 79: 26-30.
3. Ho JJ, Subramaniam P, Henderson-Smart DJ, Davis PG. Continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst. Rev. 2002; 2: CD002271.
4. Subramaniam P, Henderson-Smart DJ, Davis PG. Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infants. Cochrane Database Syst. Rev. 2002; 2: CD001243.
5. Aly HZ. Nasal prongs continuous positive airway pressure: a simple yet powerful tool. Pediatrics 2001; 108: 759-61.
6. Lindner W, Vossbeck S, Hummler H, Pohlandt F. Delivery room management of extremely low birth weight infants: spontaneous breathing or intubation? Pediatrics 1999; 103: 961-7.
7. Jacobsen T, Gronvall J, Petersen S, Andersen GE. 'Minitouch' treatment of very low-birth-weight infants. Acta Paediatr. 1993; 82: 934-8.
8. Morley CJ, Davis P, Doyle L. Continuous positive airway pressure: randomized, controlled trial in Australia. Pediatrics 2001; 108: 1383.
9. De Klerk AM, De Klerk RK. Nasal continuous positive airway pressure and outcomes of preterm infants. J. Paediatr. Child Health 2001; 37: 161-7.
10. Sinkin RA, Cox C, Phelps DL. Predicting risk for bronchopulmonary dysplasia: selection criteria for clinical trials. Pediatrics 1990; 86: 728-36.
11. Hentschel J, Friedel C, Maier RF, Bassir C, Obladen M. Predicting chronic lung disease in very low birthweight infants: comparison of 3 scores. J. Perinat. Med. 1998; 26: 378-83.
12. Davis PG, Henderson-Smart DJ. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst. Rev. 2000 3: CD000143.
13. Byrne BJ, Meilen BG, Lindstrom DP, Cotton RB. Is the BPD epidemic diminishing? Semin. Perinatol. 2002; 26: 461-6.
14. Crowley PA. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972-94. Am. J. Obstet. Gynecol. 1995; 173: 322-35.
15. Speer CP. Inflammation and bronchopulmonary dysplasia. Semin. Neonatol. 2003; 8: 29-38.
16. Jobe AH. Antenatal factors and the development of bronchopulmonary dysplasia. Semin. Neonatol. 2003; 8: 9-17.
17. Saugstad OD. Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin. Neonatol. 2003; 8: 39-49.
18. Bancalari E, Claure N, Sosenko IR. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin. Neonatol. 2003; 8: 63-71.
19. Jobe AJ. The new BPD: an arrest of lung development. Pediatr. Res. 1999; 46: 641-3.
20. Halliday HL, Ehrenkranz RA, Doyle LW. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst. Rev. 2003 1: CD001144.
21. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
22. Copper RL, Goldenberg RL, Creasy RK et al. A multicenter study of preterm birth weight and gestational age-specific neonatal mortality. Am. J. Obstet. Cynecol. 1993; 168: 78-84.
23. Gortner L, Wauer RR, Stock GJ et al. Neonatal outcome in small for gestational age infants: do they really better? J. Perinat. Med. 1999; 27: 484-9.
24. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97: 210-15.
25. Miralles RE, Hodge R, Kotecha S. Antenatal inflammation and infection in chronic lung disease of prematurity. Child Care Health Dev 2002; 28 (Suppl. 1): 11-15.
26. Ghidini A, Salafia CM, Minior VK. Lack of relationship between histologie chorioamnionitis and duration of the latency period in preterm rupture of membranes. J. Matern. Fetal Med. 1998; 7: 238-42.
27. Watts DH, Krohn MA, Hillier SL, Eschenbach DA. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet. Cynecol. 1992; 79: 351-7.
28. Horbar JD. Antenatal corticosteroid treatment and neonatal outcomes for infants 501-1500 gm in the Vermont-Oxford Trials Network. Am. J. Obstet. Gynecol. 1995; 173: 275-81.
29. Wright LL, Verier J, Younes N et al. Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: the NICHD Neonatal Research Network. Am. J. Obstet. Gynecol. 1995; 173: 269-74.